These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 27862227)

  • 41. Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses.
    Zuberbier T
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):9-18. PubMed ID: 21797930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients.
    De A; Godse K; Dhoot D; Sarda A
    Indian J Dermatol; 2021; 66(2):159-164. PubMed ID: 34188271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis.
    Guillén-Aguinaga S; Jáuregui Presa I; Aguinaga-Ontoso E; Guillén-Grima F; Ferrer M
    Br J Dermatol; 2016 Dec; 175(6):1153-1165. PubMed ID: 27237730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
    Bachert C; Kuna P; Sanquer F; Ivan P; Dimitrov V; Gorina MM; van de Heyning P; Loureiro A;
    Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative Efficacy and Acceptability of Licensed Dose Second-Generation Antihistamines in Chronic Spontaneous Urticaria: A Network Meta-Analysis.
    Phinyo P; Koompawichit P; Nochaiwong S; Tovanabutra N; Chiewchanvit S; Chuamanochan M
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):956-970.e57. PubMed ID: 32916325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognitive Performance Effects of Bilastine 20 mg During 6 Hours at 8000 ft Cabin Altitude.
    Valk PJ; Simons R; Jetten AM; Valiente R; Labeaga L
    Aerosp Med Hum Perform; 2016 Jul; 87(7):622-7. PubMed ID: 27503042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Second-generation H1-antihistamines in chronic urticaria: an evidence-based review.
    Kavosh ER; Khan DA
    Am J Clin Dermatol; 2011 Dec; 12(6):361-76. PubMed ID: 21967114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
    Kapp A; Pichler WJ
    Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
    Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial.
    Dakhale GN; Shinde AT; Mahatme MS; Hiware SK; Mishra DB; Mukhi JI; Salve AM
    Int J Dermatol; 2014 May; 53(5):643-9. PubMed ID: 24320728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options.
    Church MK; Canonica GW; Kuna P; Maurer M; Mösges R; Novak Z; Papadopoulos NG; Rodriguez Del Rio P;
    Expert Rev Clin Immunol; 2023; 19(7):813-820. PubMed ID: 37191185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria.
    Hide M; Park HS; Igarashi A; Ye YM; Kim TB; Yagami A; Roh J; Lee JH; Chinuki Y; Youn SW; Lee SK; Inomata N; Choi JH; Fukunaga A; Wang J; Matsushima S; Greenberg S; Khalil S
    J Dermatol Sci; 2017 Jul; 87(1):70-78. PubMed ID: 28366435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
    Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
    Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical toxicity profile of oral bilastine.
    Lucero ML; Arteche JK; Sommer EW; Casadesus A
    Drug Chem Toxicol; 2012 Jun; 35 Suppl 1():25-33. PubMed ID: 22616813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
    Bousquet J; Ansótegui I; Canonica GW; Zuberbier T; Baena-Cagnani CE; Bachert C; Cruz AA; González SN; Kuna P; Morais-Almeida M; Mullol J; Ryan DP; Sánchez-Borges M; Valiente R; Church MK
    Curr Med Res Opin; 2012 Jan; 28(1):131-9. PubMed ID: 22149770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study.
    Sinha VV; Kalikar MV; Mukhi JI; Giradkar AB; Sontakke S
    Perspect Clin Res; 2023; 14(4):180-186. PubMed ID: 38025284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal.
    Sánchez J; Zakzuk J; Cardona R
    J Investig Allergol Clin Immunol; 2016; 26(3):177-84. PubMed ID: 27326985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria.
    Shah B; Dhoot D; Choudhary A; Jangid N; Mistry D; Shah S; Kamat S; Barkate H
    Clin Cosmet Investig Dermatol; 2022; 15():261-270. PubMed ID: 35221703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.